ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE......FI..........................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0850067A119980701EP96924519.01996071719980202enenen1995060146519950717US1998070119982719980701199827

A61K 38/ 22 A I

A61K 31/ 00 A I

A61K 31/ 135 A I

A61K 31/ 138 A I

A61K 31/ 19 A I

A61K 31/ 192 A I

A61K 31/ 505 A I

A61K 31/ 517 A I

A61K 31/ 529 A I

A61K 31/ 70 A I

A61K 31/ 7028 A I

A61K 31/ 7034 A I

A61K 31/ 704 A I

A61K 45/ 06 A I

A61P 5/ 30 A I

A61P 35/ 00 A I

A61P 35/ 02 A I

enMETHOD FOR TREATING CANCERS USING 6- 3- 1-ADAMANTYL]-4-HYDROXYPHENYL]frPROCEDES DE TRAITEMENT DE CANCERS A L'AIDE DE 6- 3- 1-ADAMANTYL]-4-HYDROXYPHENYL]deVERFAHREN ZUR KREBSBEHANDLUNG UNTER VERWENDUNG VON 6-(3-(1-ADAMANTYL)-4-HYDROXYPHENYL)2 NAPHTALINCARBONSÄURECENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA)635, route des Lucioles, Sophia AntipolisF-06560 ValbonneFRFONTANA, Joseph, A.10161 Maxine StreetEllicott City, MD 21043USGoldin, Douglas Michael, et alJ.A. KEMP & CO. 14 South Square Gray's InnLondon WC1R 5LXGBATBECHDEDKESFIFRGBGRIEITLILUMCNLPTSEUS199601173619960717enWO199700368219970206199707